Several proteins were regulated with semaglutide, after accounting for changes in body weight and HbA 1c at end of trial, suggesting effects of semaglutide on the proteome beyond weight loss and glucose lowering
Novel drugs approved by the EMA, FDA, and MHRA in 2023
First came GIP, a hormone from the upper small intestine that surges when fat and carbohydrates arrive
Compared to other peptides such as TB-500 and GHK-Cu, BPC-157 demonstrates a more pronounced effect on tissue repair and inflammation reduction
Healthcare providers increasingly prescribe these medications off-label for metabolic optimization in appropriate clinical contexts
Common Side Effects The most frequently reported side effects include: Nausea, vomiting, diarrhea, constipation Abdominal pain and bloating Headache and fatigue Dyspepsia (indigestion) and heartburn Dizziness Injection site reactions (redness, itching, swelling) Seek Immediate Medical Attention For Severe, persistent abdominal pain (possible pancreatitis) Lump or swelling in the neck, hoarseness, trouble swallowing, or shortness of breath (possible thyroid tumor) Signs of a serious allergic reaction: swelling of face, lips, tongue, throat